Clinical trial

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

NCT00294437

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2003-12-01

PhasePHASE3

Study timeline

Study start (unknown)2003-12-01Date precision: month

Registry last updated2012-05-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

ZometaDRUG

Sponsors & collaborators

Central European Cooperative Oncology Grouplead sponsor

Mapped research locations

BudapestHungary3 SofiaBulgaria3 BelgradeSerbia3 WarsawPoland2 BucharestRomania2 LinzAustria2 MoscowRussia1 PragueCzechia1 KrakowPoland1 BrnoCzechia1 BratislavaSlovakia1 PlovdivBulgaria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00294437 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.